A pro-apoptotic selection strategy enables CRISPR screening in mosquitoes and identifies Lachesin as a chikungunya virus entry factor

Imagine the microscopic world of a virus as a master thief trying to break into a high-security bank. The bank is a living cell, and the thief is a virus like Chikungunya. To get inside, the thief needs a specific key that fits the bank's front door. In humans, scientists have already found many of these keys, but when it comes to the mosquitoes that carry the virus, the doors are a mystery. We know the virus travels from mosquito to human, but we don't fully understand how it slips into the mosquito's cells in the first place. This is where the science of "CRISPR screening" comes in. Think of CRISPR as a giant, precise pair of molecular scissors that can snip out specific genes (the instruction manuals inside a cell) one by one. By cutting out different instructions and seeing which ones stop the virus from working, scientists can figure out which "keys" the virus needs to enter. The big challenge, however, has been that mosquito cells are tough to test; if you cut out a gene and the virus just ignores it, you have no easy way to tell which cells are still infected and which are safe.

This paper tells the story of how researchers cracked this code to find the missing keys for Chikungunya virus in mosquitoes. The team faced a tricky problem: how do you spot the cells that successfully blocked the virus? Their clever solution was to turn the virus into a "suicide bomber" for the cells. They engineered the Chikungunya virus to carry a tiny, dangerous protein called Reaper. In the world of these mosquito cells, Reaper is like a red alarm button that, when pressed, tells the cell to self-destruct. If the virus gets in, it presses the button, and the cell dies. But if the cell is missing a specific "entry key" (a gene the virus needs), the virus can't get in, the alarm never sounds, and the cell survives. By using this "pro-apoptotic" (cell-killing) strategy, the researchers could easily separate the survivors from the victims.

Using this clever trap, the scientists performed a massive search, cutting out thousands of different genes in mosquito cells to see which ones were essential for the virus to enter. They discovered that the virus relies heavily on a special type of anchor on the cell's surface called a GPI-anchor, and specifically, a protein named Lachesin. When they removed Lachesin, the virus couldn't get in. To prove this was real, they did the opposite: they took human cells that are normally immune to Chikungunya and gave them the Lachesin protein. Suddenly, those human cells became vulnerable to the virus. The study also showed that this key works for related viruses like Semliki Forest virus and Ross River virus, but interestingly, it doesn't work for a different virus called Venezuelan equine encephalitis virus, suggesting that different viruses use different keys even if they are in the same family.

The researchers confirmed that Lachesin is a critical entry factor for Chikungunya in both major mosquito species, Aedes aegypti and Aedes albopictus, by silencing the gene and watching the infection stop. While the paper establishes Lachesin as a critical candidate for how the virus enters, it presents this as a major step forward in understanding the virus's mechanics rather than a finished cure. The study suggests that using these "suicide" viruses is a powerful new way to screen for other mosquito-borne diseases, offering a versatile tool for future discovery without claiming to have solved the entire problem of transmission yet.